Mapping complex disease traits with global gene expression

Nature Reviews Genetics

Volumn 10, Issue 3, 2009, Pages 184-194

  Cookson, William ^a   Liang, Liming ^b   Abecasis, Gonçalo ^b   Moffatt, Miriam ^a   Lathrop, Mark ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Center for Statistical Genetics   (United States)

^c DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; GENE EXPRESSION; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; QUANTITATIVE TRAIT LOCI;

EID: 60349092402     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2537     Document Type: Review

References (110)

1. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
2. Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genet. 38, 441-446 (2006).
3. Burton, P. R. et al. Association scan of 14,500 non-synonymous SNPs in four diseases identifies autoimmunity variants. Nature Genet. 39, 1329-1337 (2007).
4. Schadt, E. E. et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 422, 297-302 (2003). This paper shows the power of eQTL analysis in humans.
5. Morley, M. et al. Genetic analysis of genome-wide variation in human gene expression. Nature 430, 743-747 (2004).
6. Brem, R. B., Yvert, G., Clinton, R. & Kruglyak, L. Genetic dissection of transcriptional regulation in budding yeast. Science 296, 752-755 (2002).
7. Rockman, M. V. & Kruglyak, L. Genetics of global gene expression. Nature Rev. Genet. 7, 862-872 (2006).
8. Gilad, Y., Rifkin, S. A. & Pritchard, J. K. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet. 24, 408-415 (2008).
9. Jia, Z. & Xu, S. Mapping quantitative trait loci for expression abundance. Genetics 176, 611-623 (2007).
10. Carlborg, O. et al. Methodological aspects of the genetic dissection of gene expression. Bioinformatics 21, 2383-2393 (2005).
11. Kendziorski, C. M., Chen, M., Yuan, M., Lan, H. & Attie, A. D. Statistical methods for expression quantitative trait loci (eQTL) mapping. Biometrics 62, 19-27 (2006).
12. Schliekelman, P. Statistical power of expression quantitative trait loci for mapping of complex trait loci in natural populations. Genetics 178, 2201-2216 (2008).
13. Dixon, A. L. et al. A genome-wide association study of global gene expression. Nature Genet. 39, 1202-1207 (2007).
14. Visscher, P. M., Hill, W. G. & Wray, N. R. Heritability in the genomics era - concepts and misconceptions. Nature Rev. Genet. 9, 255-266 (2008).
15. Goring, H. H. et al. Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nature Genet. 39, 1208-1216 (2007).
16. Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423-428 (2008). This paper illustrates the power of eQTL and network analysis in unravelling complex trait genetics.
17. Schadt, E. E. et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).
18. Petretto, E. et al. Heritability and tissue specificity of expression quantitative trait loci. PLoS Genet. 2, e172 (2006).
19. Monks, S. A. et al. Genetic inheritance of gene expression in human cell lines. Am. J. Hum. Genet. 75, 1094-1105 (2004).
20. Veyrieras, J. B. et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008).
21. Hubner, N. et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nature Genet. 37, 243-253 (2005).
22. Yvert, G. et al. Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factors. Nature Genet. 35, 57-64 (2003).
23. Shimada, M. K. et al. VarySysDB: a human genetic polymorphism database based on all H-InvDB transcripts. Nucleic Acids Res. 37, D810-D815 (2008).
24. Stranger, B. E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-853 (2007).
25. Gonzales, J. M. et al. Regulatory hotspots in the malaria parasite genome dictate transcriptional variation. PLoS Biol. 6, e238 (2008).
26. Mileyko, Y., Joh, R. I. & Weitz, J. S. Small-scale copy number variation and large-scale changes in gene expression. Proc. Natl Acad. Sci. USA 105, 16659-16664 (2008).
27. Eckhardt, F. et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nature Genet. 38, 1378-1385 (2006). This paper shows the extent and distribution of methylation in the human genome.
28. Krebs, J. E. Moving marks: dynamic histone modifications in yeast. Mol. Biosyst. 3, 590-597 (2007).
29. Myers, A. J. et al. A survey of genetic human cortical gene expression. Nature Genet. 39, 1494-1499 (2007).
30. Moffatt, M. F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470-473 (2007).
31. Bouzigon, E. et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N. Engl. J. Med. 359, 1985-1994 (2008).
32. Duan, S. et al. Genetic architecture of transcript-level variation in humans. Am. J. Hum. Genet. 82, 1101-1113 (2008).
33. Galanter, J. et al. ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am. J. Respir. Crit. Care Med. 177, 1194-1200 (2008).
34. Sleiman, P. M. et al. ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestry. J. Allergy Clin. Immunol. 122, 1225-1227 (2008).
35. Tavendale, R., Macgregor, D. F., Mukhopadhyay, S. & Palmer, C. N. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J. Allergy Clin. Immunol. 121, 860-863 (2008).
36. Barrett, J. C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nature Genet. 40, 955-962 (2008). A substantial meta-analysis of susceptibility loci underlying Crohn's disease that illustrates the problem of unattributed heritability and the utility of eQTL data in understanding the function of disease-associated SNPs.
37. Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).
38. Kabashima, K. et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883-893 (2002).
39. Rioux, J. D. et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genet. 29, 223-228 (2001).
40. Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nature Genet. 41, 56-65 (2009).
41. Willer, C. J. et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genet. 41, 25-34 (2009).
42. Horton, R. et al. Gene map of the extended human MHC. Nature Rev. Genet. 5, 889-899 (2004).
43. Alberts, R. et al. Sequence polymorphisms cause many false cis eQTLs. PLoS ONE 2, e622 (2007).
44. Beaty, J. S., West, K. A. & Nepom, G. T. Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1. Mol. Cell. Biol. 15, 4771-4782 (1995).
45. Nejentsev, S. et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450, 887-892 (2007).
46. Sieberts, S. K. & Schadt, E. E. Moving toward a system genetics view of disease. Mamm. Genome 18, 389-401 (2007).
47. Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-1935 (2006).
48. Goh, K. I. et al. The human disease network. Proc. Natl Acad. Sci. USA 104, 8685-8690 (2007).
49. Chen, Y. et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452, 429-435 (2008).
50. Barnes, M., Freudenberg, J., Thompson, S., Aronow, B. & Pavlidis, P. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Nucleic Acids Res. 33, 5914-5923 (2005).
51. Pedotti, P. et al. Can subtle changes in gene expression be consistently detected with different microarray platforms? BMC Genomics 9, 124 (2008).
52. van Ruissen, F. et al. Evaluation of the similarity of gene expression data estimated with SAGE and Affymetrix GeneChips. BMC Genomics 6, 91 (2005).
53. Bosotti, R. et al. Cross platform microarray analysis for robust identification of differentially expressed genes. BMC Bioinformatics 8 (Suppl. 1), S5 (2007).
54. Ji, Y. et al. RefSeq refinements of UniGene-based gene matching improve the correlation of expression measurements between two microarray platforms. Appl. Bioinformatics 5, 89-98 (2006).
55. Carter, S. L., Eklund, A. C., Mecham, B. H., Kohane, I. S. & Szallasi, Z. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements. BMC Bioinformatics 6, 107 (2005).
56. Sohail, M., Akhtar, S. & Southern, E. M. The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotides. RNA 5, 646-655 (1999).
57. Southern, E., Mir, K. & Shchepinov, M. Molecular interactions on microarrays. Nature Genet. 21, 5-9 (1999). This review, by the inventor of DNA microarrays, highlights the complexity and unpredictability of the interactions between nucleic acids in solution and target sequences on solid supports.
58. Kapur, K., Xing, Y., Ouyang, Z. & Wong, W. H. Exon arrays provide accurate assessments of gene expression. Genome Biol. 8, R82 (2007).
59. Okoniewski, M. J., Hey, Y., Pepper, S. D. & Miller, C. J. High correspondence between Affymetrix exon and standard expression arrays. Biotechniques 42, 181-185 (2007).
60. Clark, T. A. et al. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol. 8, R64 (2007).
61. Wold, B. & Myers, R. M. Sequence census methods for functional genomics. Nature Methods 5, 19-21 (2008).
62. Watson, R. M., Griaznova, O. I., Long, C. M. & Holland, M. J. Increased sample capacity for genotyping and expression profiling by kinetic polymerase chain reaction. Anal. Biochem. 329, 58-67 (2004).
63. Weedon, M. N. et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nature Genet. 40, 575-583 (2008).
64. Brem, R. B. & Kruglyak, L. The landscape of genetic complexity across 5,700 gene expression traits in yeast. Proc. Natl Acad. Sci. USA 102, 1572-1577 (2005).
65. Moffatt, M. & Cookson, W. The genetics of asthma. Maternal effects in atopic disease. Clin. Exp. Allergy 28 (Suppl. 1), 56-61 (1998).
66. Bennett, S. & Todd, J. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu. Rev. Genet. 30, 343-370 (1996).
67. Warram, J. H., Krolewski, A. S., Gottlieb, M. S. & Kahn, C. R. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N. Engl. J. Med. 311, 149-152 (1984).
68. Koumantaki, Y. et al. Family history as a risk factor for rheumatoid arthritis: a case-control study. J. Rheumatol. 24, 1522-1526 (1997).
69. Burden, A. et al. Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J. Invest. Dermatol. 110, 958-960 (1998);
70. comment 112, 514-516 (1999).
71. Akolkar, P. N. et al. Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease. Am. J. Gastroenterol. 92, 2241-2244 (1997).
72. Vorechovsky, I., Webster, A. D., Plebani, A. & Hammarstrom, L. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am. J. Hum. Genet. 64, 1096-1109 (1999).
73. Grosshans, H. & Filipowicz, W. Molecular biology: the expanding world of small RNAs. Nature 451, 414-416 (2008).
74. Plagnol, V. et al. Extreme clonality in lymphoblastoid cell lines with implications for allele specific expression analyses. PLoS ONE 3, e2966 (2008).
75. Yan, H., Yuan, W., Velculescu, V. E., Vogelstein, B. & Kinzler, K. W. Allelic variation in human gene expression. Science 297, 1143 (2002).
76. Cheung, V. G. et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nature Genet. 33, 422-425 (2003).
77. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nature Genet. 35, 131-138 (2003).
78. Kohane, I. S., Kho, A. T. & Butte, A. J. Microarrays for an Integrative Genomics (MIT Press, Cambridge, Massachusetts, 2002).
79. Idaghdour, Y., Storey, J. D., Jadallah, S. J. & Gibson, G. A genome-wide gene expression signature of environmental geography in leukocytes of Moroccan Amazighs. PLoS Genet. 4, e1000052 (2008). Although this paper describes a small study, it shows the profound effects of different environments on gene expression in peripheral blood lymphocytes.
80. Li, Y. et al. Mapping determinants of gene expression plasticity by genetical genomics in C. elegans. PLoS Genet. 2, e222 (2006).
81. Smith, E. N. & Kruglyak, L. Gene-environment interaction in yeast gene expression. PLoS Biol. 6, e83 (2008).
82. Gibson, G. The environmental contribution to gene expression profiles. Nature Rev. Genet. 9, 575-581 (2008).
83. Reis, B. Y., Butte, A. S. & Kohane, I. S. Extracting knowledge from dynamics in gene expression. J. Biomed. Inform. 34, 15-27 (2001). This paper shows the utility of using time-series measurements of gene expression to identify co-regulated modules of genes.
84. Schadt, E. E. & Lum, P. Y. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J. Lipid Res. 47, 2601-2613 (2006).
85. Gudbjartsson, D. F. et al. Many sequence variants affecting diversity of adult human height. Nature Genet. 40, 609-615 (2008).
86. Hom, G. et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358, 900-909 (2008).
87. Hakonarson, H. et al. A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes 57, 1143-1146 (2008).
88. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
89. Todd, J. A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genet. 39, 857-864 (2007).
90. Plenge, R. M. et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N. Engl. J. Med. 357, 1199-1209 (2007).
91. Thein, S. L. et al. Intergenic variants of HBS1L-MYB are responsible for a major QTL on chromosome 6q23 influencing HbF levels in adults. Proc. Natl Acad. Sci. USA (in the press).
92. Di Bernardo, M. C. et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nature Genet. 40, 1204-1210 (2008).
93. Gardner, T. S., di Bernardo, D., Lorenz, D. & Collins, J. J. Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301, 102-105 (2003).
94. Sontag, E., Kiyatkin, A. & Kholodenko, B. N. Inferring dynamic architecture of cellular networks using time series of gene expression, protein and metabolite data. Bioinformatics 20, 1877-1886 (2004).
95. Li, H. et al. Integrative genetic analysis of transcription modules: towards filling the gap between genetic loci and inherited traits. Hum. Mol. Genet. 15, 481-492 (2006).
96. Keurentjes, J. J. et al. Regulatory network construction in Arabidopsis by using genome-wide gene expression quantitative trait loci. Proc. Natl Acad. Sci. USA 104, 1708-1713 (2007).
97. Gerrits, A., Dykstra, B., Otten, M., Bystrykh, L. & de Haan, G. Combining transcriptional profiling and genetic linkage analysis to uncover gene networks operating in hematopoietic stem cells and their progeny. Immunogenetics 60, 411-422 (2008).
98. de Koning, D. J., Carlborg, O. & Haley, C. S. The genetic dissection of immune response using gene-expression studies and genome mapping. Vet. Immunol. Immunopathol. 105, 343-352 (2005).
99. Akey, J. M., Biswas, S., Leek, J. T. & Storey, J. D. On the design and analysis of gene expression studies in human populations. Nature Genet. 39, 807-808; author reply 808-809 (2007).
100. Spielman, R. S. et al. Common genetic variants account for differences in gene expression among ethnic groups. Nature Genet. 39, 226-231 (2007).
101. Doss, S., Schadt, E. E., Drake, T. A. & Lusis, A. J. Cis-acting expression quantitative trait loci in mice. Genome Res. 15, 681-691 (2005).
102. Hughes, T. R. et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nature Biotechnol. 19, 342-347 (2001).
103. Alberts, R., Terpstra, P., Bystrykh, L. V., de Haan, G. & Jansen, R. C. A statistical multiprobe model for analyzing cis and trans genes in genetical genomics experiments with short-oligonucleotide arrays. Genetics 171, 1437-1439 (2005).
104. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355 (2008).
105. Sun, Z., Wigle, D. A. & Yang, P. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival. J. Clin. Oncol. 26, 877-883 (2008).
106. Walker, B. A. et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood 108, 1733-1743 (2006).
107. Lastowska, M. et al. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene 26, 7432-7444 (2007).
108. Huang, R. S. et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc. Natl Acad. Sci. USA 104, 9758-9763 (2007).
109. Zhang, B. & Horvath, S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4, Article17 (2005). This paper describes a statistical approach to network analyses and provides a set of software tools for their implementation.
110. Horvath, S. et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl Acad. Sci. USA 103, 17402-17407 (2006).